Study of the Effectiveness of Quetiapine for the Treatment of Alcohol Dependency
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether quetiapine fumarate extended release is
effective in the treatment of alcohol dependence in very heavy drinkers.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborators:
AstraZeneca National Institute on Drug Abuse (NIDA) US Department of Veterans Affairs VA Office of Research and Development